glp-1 and general anesthesia Glucagon-Like Peptide 1 Receptor Agonists Aspiration Risk Glucagon-Like Peptide-1 Receptor Agonists in

Clinical trial data and post-marketing surveillance indicate that gastrointestinal adverse effects are among the most frequent reasons for treatment discontinuation

GIP: Glucose-dependent insulinotropic polypeptide

In one such video, a svelte young woman on a couch asks a doctor, "I'm only looking to lose a couple of pounds, maybe use it temporarily." The doctor assures her it's fine for brief use

Obesity disproportionately affects children living in areas of deprivation and from ethnic minority groups

Refined carbohydrates involve processed grains, refined flours, starches, and added sugars

Pay attention to physical hunger vs